Alberto Mantovani

Alberto Mantovani is a Professor and Chair of Inflammation and Therapeutic Innovation at Queen Mary University of London's Faculty of Medicine and Dentistry, and Emeritus Professor of Pathology at Humanitas University in Milan. He serves as Scientific Director of the Istituto Clinico Humanitas. His research focuses on innate immunity, tumor-associated macrophages (TAM), cancer progression, and the role of inflammation in disease. He has pioneered studies on cytokines, chemokines, and the IL-1 receptor family, with contributions to understanding PTX3's role in cancer and viral infections like COVID-19.

Key honors include the Robert Koch Award, American Association for Cancer Research International Pezcoller Award, and International Feltrinelli Prize. He has over 137,000 citations and an H-index of 173. His memberships include EMBO, Accademia dei Lincei, and Academia Europaea. He actively promotes science communication through books and media, addressing public health issues like vaccines and pandemic response.

Research interests span tumor immunology, cytokine networks, and translational medicine. He leads interdisciplinary teams at the William Harvey Research Institute, emphasizing therapeutic innovation and inflammation-cancer links. His work bridges basic science and clinical applications, with a focus on biomarkers and immune modulation strategies.